Correction: Breast cancer in neurofibromatosis 1: survival and risk of contralateral breast cancer in a five country cohort study

D Gareth R Evans; Roope A Kallionpää; Maurizio Clementi; Eva Trevisson; Victor-Felix Mautner; Sacha J Howell; Lauren Lewis; Ouidad Zehou; Sirkku Peltonen; Antonella Brunello; Elaine F Harkness; Pierre Wolkenstein; Juha Peltonen

doi:10.1038/s41436-019-0671-2

Correction: Breast cancer in neurofibromatosis 1: survival and risk of contralateral breast cancer in a five country cohort study

Genet Med. 2020 Jan;22(1):242. doi: 10.1038/s41436-019-0671-2.

Authors

D Gareth R Evans^#^{1

2

3

4}, Roope A Kallionpää^#⁵, Maurizio Clementi⁶, Eva Trevisson⁶, Victor-Felix Mautner⁷, Sacha J Howell^{1

4

8}, Lauren Lewis², Ouidad Zehou⁹, Sirkku Peltonen¹⁰, Antonella Brunello¹¹, Elaine F Harkness^{4

12}, Pierre Wolkenstein⁹, Juha Peltonen¹³

Affiliations

¹ The Christie NHS Foundation Trust, Manchester, UK.
² Manchester Centre for Genomic Medicine, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK.
³ Division of Evolution and Genomic Sciences, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK.
⁴ Genesis Breast Cancer Prevention Centre and Nightingale Breast Screening Centre, University Hospital of South Manchester, Manchester Academic Health Science Centre, Manchester, UK.
⁵ Institute of Biomedicine, University of Turku, Turku, Finland.
⁶ Clinical Genetics Unit, Deparment of Women's and Children's Health, University of Padova, Padova, Italy.
⁷ Phacomatoses Department, Department of Neurology, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany.
⁸ Division of Cancer Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester Academic Health Science Centre, Manchester, UK.
⁹ Referral Centre for Neurofibromatoses Dermatology, Hôpital Henri Mondor, APHP, UPEC, Créteil, France.
¹⁰ Department of Dermatology, University of Turku and Turku University Hospital, Turku, Finland.
¹¹ Medical Oncology 1 Unit, Department of Oncology, Istituto Oncologico Veneto IOV - IRCCS, Padova, Italy.
¹² Division of Informatics, Imaging and Data Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.
¹³ Institute of Biomedicine, University of Turku, Turku, Finland. [email protected].

^# Contributed equally.

Abstract

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

Publication types

Published Erratum